EX-21 4 dp04864_ex21.htm Unassociated Document
 
EXHIBIT 21
 
LIST OF SUBSIDIARIES
 
 
Principal subsidiary/undertaking
Jurisdiction of incorporation
   
Shire Pharmaceuticals Group Limited
England and Wales
Shire LLC
State of Kentucky, USA
Shire Pharmaceuticals Limited
England and Wales
Shire Pharmaceuticals Development Limited
England and Wales
Shire International Licensing BV
Netherlands
Shire Pharmaceuticals, Inc.
State of Delaware, USA
Shire Development, Inc.
State of Delaware, USA
Shire Regulatory, Inc.
State of Delaware, USA
Shire France S A
France
Shire Deutschland GmbH & Co. KG
Germany
Shire US, Inc.
State of New Jersey, USA
Shire Pharmaceuticals Ireland Limited
Republic of Ireland
Shire Italia SpA
Italy
Shire Pharmaceuticals Iberica S.L.
Spain
Shire Pharmaceuticals US Development, Inc.
State of Maryland, USA
Shire BioChem, Inc.
Canada
Shire Pharmaceutical Contracts Limited
England and Wales
Shire US Manufacturing, Inc.
State of Maryland, USA
Shire Human Genetic Therapies, Inc. (formerly Transkaryotic Therapies, Inc.)
 
State of Delaware, USA
Shire Human Genetic Therapies AB (formerly TKT
Europe AB)
 
Sweden

 
All subsidiary undertakings of Shire plc are beneficially owned (directly or indirectly) as to 100% and are all consolidated in the consolidated financial statements of Shire plc.